Personalis, Inc. - stock earnings
PSNL Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 8, 2024 AfterMarket | - / -0.4223000000 | - | - / 18.7 million | - |
PSNL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -26.6 million USD | 19.7 million USD |
| 2023Q3 | -29.1 million USD | 18.2 million USD |
| 2023Q2 | -24.0 million USD | 16.7 million USD |
| 2023Q1 | -28.7 million USD | 18.9 million USD |
| 2022Q4 | -31.1 million USD | 16.7 million USD |
| 2022Q3 | -26.5 million USD | 14.9 million USD |
| 2022Q2 | -27.5 million USD | 18.2 million USD |
| 2022Q1 | -28.2 million USD | 15.2 million USD |
| 2021Q4 | -20.2 million USD | 20.7 million USD |
| 2021Q3 | -17.7 million USD | 22.3 million USD |
| 2021Q2 | -15.0 million USD | 21.7 million USD |
| 2021Q1 | -12.4 million USD | 20.9 million USD |
| 2020Q4 | -13.3 million USD | 20.2 million USD |
| 2020Q3 | -9.5 million USD | 19.8 million USD |
| 2020Q2 | -9.3 million USD | 19.5 million USD |
| 2020Q1 | -9.1 million USD | 19.2 million USD |
| 2019Q4 | -6.6 million USD | 18.2 million USD |
| 2019Q3 | -6.9 million USD | 17.2 million USD |
| 2019Q2 | -5.9 million USD | 15.8 million USD |
| 2019Q1 | -5.7 million USD | 14.1 million USD |
| 2018Q4 | -3.6 million USD | 13.2 million USD |
| 2018Q3 | -3.6 million USD | 11.7 million USD |
| 2018Q2 | -7.3 million USD | 8.8 million USD |
| 2018Q1 | -5.4 million USD | 4.2 million USD |
PSNL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -108.3 million USD | 73.5 million USD |
| 2022 | -113.3 million USD | 65.0 million USD |
| 2021 | -65.2 million USD | 85.5 million USD |
| 2020 | -41.3 million USD | 78.6 million USD |
| 2019 | -25.1 million USD | 65.2 million USD |
| 2018 | -19.9 million USD | 37.8 million USD |
| 2017 | -23.6 million USD | 9.4 million USD |
PSNL
Price: $1.58
52 week price:
Earnings Per Share: -2.25 USD
P/E Ratio: -0.50
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 192700
Market Capitalization: 71.7 million